Literature DB >> 12460047

Prospective evaluation of the intra-access flow of recently created native arteriovenous fistulae.

Violaine Begin1, Jean Ethier, Marc Dumont, Martine Leblanc.   

Abstract

BACKGROUND: The aim of this study is to assess the evolution of intra-access flow (Q(ac)) in recently created native arteriovenous fistulae (AVFs) during the first few months of use.
METHODS: All AVFs were monitored by means of ultrasound dilution using Transonic (Transonic Systems Inc, Ithaca, NY). First Q(ac) measurements were obtained between 6 to 10 weeks after creation and subsequently every 3 to 6 weeks during the following 4 months. Per routine, AVFs are cannulated 6 weeks after their creation in our unit. Fifty-seven patients with new AVFs were initially enrolled, but 12 patients were lost at follow-up. There was a 69% to 31% ratio of brachiocephalic (BC) to radiocephalic (RC) AVFs, and diabetes affected an equal proportion of patients in both subtypes.
RESULTS: Mean initial and final Q(ac)s were 1,132 +/- 681 and 1,097 +/- 644 mL/min, respectively; there was no significant difference during the study period. However, the Q(ac) of BC AVFs remained approximately twice as high as the Q(ac) of RC AVFs during the observation period (initial Q(ac), 1,336 +/- 689 versus 645 +/- 332 mL/min; final Q(ac), 1,285 +/- 652 versus 647 +/- 331 mL/min, respectively). Male sex was associated with a greater Q(ac) throughout the evaluation (1,263 +/- 754 versus 852 +/- 375 mL/min for women). No significant difference was noted between different age groups, and diabetes did not significantly affect Q(ac). Finally, the initial Q(ac) of a BC AVF was influenced by the presence of a previously functioning RC AVF on the same arm. The initial Q(ac) in BC AVFs was 1,800 +/- 919 mL/min in that subgroup (and decreased to 1,302 +/- 733 mL/min by the end of the study, therefore becoming similar to the mean Q(ac) of other BC AVFs).
CONCLUSION: From these results, we conclude that newly created native AVFs have an initial Q(ac) that does not vary significantly during the first 6 months and may already be maximal at 6 weeks or at the time of first needle puncture in our hands. Among demographic factors, sex influences the Q(ac) of native AVFs, whereas age and diabetes do not. Copyright 2002 by the National Kidney Foundation, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 12460047     DOI: 10.1053/ajkd.2002.36898

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  8 in total

1.  Acute systemic hypotension after arteriovenous fistula construction in a patient with severe aortic stenosis.

Authors:  Naobumi Mise; Lisa Uchida; Mototsugu Tanaka; Shinji Tanaka; Hiroyoshi Nakajima; Tokuichiro Sugimoto
Journal:  Clin Exp Nephrol       Date:  2011-07-02       Impact factor: 2.801

Review 2.  Percutaneous Creation of a Central Iliac Arteriovenous Anastomosis for the Treatment of Arterial Hypertension.

Authors:  Stefan C Bertog; Nathan A Sobotka; Paul A Sobotka; Melvin D Lobo; Kolja Sievert; Laura Vaskelyte; Horst Sievert; Roland E Schmieder
Journal:  Curr Hypertens Rep       Date:  2018-03-19       Impact factor: 5.369

3.  Relation between access blood flow and mortality in chronic hemodialysis patients.

Authors:  Mohammed Al-Ghonaim; Braden J Manns; David J Hirsch; Zhiwei Gao; Marcello Tonelli
Journal:  Clin J Am Soc Nephrol       Date:  2008-01-30       Impact factor: 8.237

4.  Association of vascular access flow with short-term and long-term mortality in chronic haemodialysis patients: a retrospective cohort study.

Authors:  Chung-Kuan Wu; Chia-Lin Wu; Chia-Hsun Lin; Jyh-Gang Leu; Chew-Teng Kor; Der-Cherng Tarng
Journal:  BMJ Open       Date:  2017-09-24       Impact factor: 2.692

5.  Impact of arteriovenous fistula blood flow on serum il-6, cardiovascular events and death: An ambispective cohort analysis of 64 Chinese hemodialysis patients.

Authors:  Zhizhi Hu; Fengmin Zhu; Nan Zhang; Chunxiu Zhang; Guangchang Pei; Pengge Wang; Juan Yang; Yujiao Guo; Meng Wang; Yuxi Wang; Qian Yang; Han Zhu; Wenhui Liao; Zhiguo Zhang; Ying Yao; Rui Zeng; Gang Xu
Journal:  PLoS One       Date:  2017-03-07       Impact factor: 3.240

6.  Arteriovenous Vascular Access Selection and Evaluation.

Authors:  Jennifer M MacRae; Matthew Oliver; Edward Clark; Christine Dipchand; Swapnil Hiremath; Joanne Kappel; Mercedeh Kiaii; Charmaine Lok; Rick Luscombe; Lisa M Miller; Louise Moist
Journal:  Can J Kidney Health Dis       Date:  2016-09-27

7.  Arteriovenous Access: Infection, Neuropathy, and Other Complications.

Authors:  Jennifer M MacRae; Christine Dipchand; Matthew Oliver; Louise Moist; Serdar Yilmaz; Charmaine Lok; Kelvin Leung; Edward Clark; Swapnil Hiremath; Joanne Kappel; Mercedeh Kiaii; Rick Luscombe; Lisa M Miller
Journal:  Can J Kidney Health Dis       Date:  2016-09-27

8.  Interrogating the haemodynamic effects of haemodialysis arteriovenous fistula on cardiac structure and function.

Authors:  Sokratis Stoumpos; Alastair Rankin; Pauline Hall Barrientos; Kenneth Mangion; Ellon McGregor; Peter C Thomson; Karen Stevenson; Paul Welsh; Ram Kasthuri; David B Kingsmore; Giles Roditi; Patrick B Mark
Journal:  Sci Rep       Date:  2021-09-13       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.